High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1504-1516

Bentham Science Publishers

Access to resources Recommend Favorite

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

By Kappelle Paul JWH   Zwang Louwerens   Huisman Menno V   Banga Jan Dirk   Sluiter Wim J   Dallinga-Thie Geesje M   Dullaart Robin PF  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 743-751

Informa Healthcare

Access to resources Recommend Favorite

Choosing Targets for Glycaemia, Blood Pressure and Low-Density Lipoprotein Cholesterol in Elderly Individuals with Diabetes Mellitus

By Kirsh Susan R.   Aron David C.  

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 945-960

Adis International

Access to resources Recommend Favorite

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

By Keating Gillian M.   Croom Katherine F.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 121-153

Adis International

Access to resources Recommend Favorite